aBSTRACT author Index 352 Fragoso-Loyo, H 1404 Frampton, C 2579 França, IL 865, 2619 França, NR 2307 Francès, C 608, 1409 Frances, C 1955 Franceschelli, F 1533 Franceschini, F 231, 232 Francis, KA 958 Francis, L 2599 Francis, RM 1104 Francisco-Hernández, F 2268 Francisco-Hernández, F 2290 Franek, BS 456, 633, 1372, 1423, 1429 Frank, C 1727 Frank, MB 489 Frank, M 42, 45, 2519 Frank, S 1938 Franke, B 165 Frankel, S 1470 Franklin, A 1778 Franklin, PD 1565 Frankovich, JD 2017, 2054, 2068 Franks, AG 536, 2323 Fransen, J 341, 673, 1180, 1717, 1878, 2585, 2596 Frantal, S 31 Fraser, AD 2419, 2641 Fraser, PA 1667 Frattasi, M 2275, 2639 Frazier, SK 868 Frech, TM 715, 903, 905, 1716, 2483 Frech-Tamas, F 896 Frederiksen, KS 1424 Fredi, M 231, 1535 Freedman, BI 632, 633, 636, 637, 641, 2476, 2479 Freeman, AF 170 Freiman, J 2593 Freimuth, W 578, 584, 1367, 1416, 2472 Freimuth, W 602 Freire, V 268, 1718 French, HP 1722 French, M 1628 French, MR 886, 2506 French Vasculitis Study Group (FVSG) 2368 French Vasculitis Study Group (FVSG)* 858 Frenkel, J 988 Frenkel, S 1781 Fresen, J 2057 Freundlich, B 515, 1329, 2534 Frey, S 1761 Frey-Law, L 742, 1089, 1541, 1627 2011 <strong>Program</strong> <strong>Book</strong> Fridén, C 2613 Friedberg, JW 1744 Friedman, A 1827 Friedman, A 496, 663, 1425 Fries, JF 910, 1885, 2556 Frits, MA 333, 2575 Fritschy, D 1081 Fritz, J 866 Fritzler, MJ 696, 708, 765, 1862, 2298 Frizelle, S 2003 Frleta, M 82 Frolov, A 1674 Frommer, K 1823, 1825 Frydrych, LM 135, 393, 844, 2143, 2150, 2516 Fu, C 2630 Fu, EHY 1371 Fu, Q 1392, 1712 Fu, Q 640 Fu, Y 1130 Fuehrer, JT 1119 Fuentes, IM 2426 Fuerst, F 2135 Fuhlbrigge, RC 2023 Fujieda, Y 15, 2310 Fujihira, E 304 Fujii, H 1434 Fujii, T 225 Fujimoto, M 1488 Fujio, K 853 Fujita, M 2095 Fujita, T 226, 236 Fukasawa, C 1483 Fukuda, S 376 Fukuda, T 1403 Fukuda, W 1199 Fukushi, J 540 Fukuyo, S 1237, 1239, 2468 Fuller, P 1999 Fuller, R 222, 581, 709 Funahashi, K 457, 1263, 2108 Funahashi, K 1214 Furer, V 52, 223 Furie, R 2265 Furie, R 578, 584, 597, 1367 Furie, R 2255, 2469 Furner, S 1539 Furst, DE 98, 221, 342, 676, 716, 1246, 1493, 1848, 1861, 1864, 2117, 2199, 2238, 2429, 2464, 2511 Furtado, RV 1719 Furukawa, F 1410 Furuya, H 66, 1277 Furuya, T 1629 Fürnrohr, BG 998 Førre, ØT 1052 G Gabay, C 160, 444, 1081, 1645, 1646, 2242, 2336, 2637 Gabay Engel, OH 1795 Gabbai, AA 2397 Gabbriellini, G 471 Gaber, T 28, 373, 1005 Gabler, M 63 Gabriel, SE 121, 761, 1183, 1184, 1187, 1511, 1632, 2104, 2113 Gabrielli, A 673, 1529 Gadina, M 818 Gaffney, PM 150, 157, 632, 633, 634, 636, 637, 639, 641, 642, 643, 649, 773, 1370, 1427, 2475, 2476, 2477, 2479 Gaffney on behalf of LLAS2, PM 1681 Gaffo, AL 1174, 1200 Gagarina, V 1795 Gaillez, C 1224, 1238, 2209, 2231, 2232 Gainer, V 1185 Gajria, K 133, 141, 1864 Galarza-Maldonado, C 2117 Galasso, JA 1551 Galasso, R 272 Galbo, H 253 Galeazzi, M 1201 Galgiani, J 2466 Galicier, L 608 Galien, R 2210 Galimberti, S 2382 Galindo, M 2349 Galindo-Izquierdo, M 2290 Gall, EP 2466 Gall, R 1014 Gallacher, A 578 Galletti, S 33 Galli, M 1529 Gallizzi, R 2452 Gallo, A 497, 498, 775, 1937 Gallo, G 429 Galloway, JB 426, 2524, 2525 Gamble, G 207, 210, 219 Gámez-Nava, I 250 Gamsa, A 1605, 1906 Gandhi, A 1844 Gandhi, C 170 Gandjbakhch, F 1068, 2235 Gandra, SR 146, 915, 1547, 2415, 2416 Ganser, G 274, 2012, 2623 Gantes-Mora, MA 1166, 2134 Ganz, R 1077 Gao, A 1618 Gao, J 285 Gao, L 1053 Gao, W 47, 732 Garabet, L 1707 Garau, P 1354 Garay, SM 2012 Garcês, S 464, 1841 Garchon, H 1340, 1706 Garcia, A 626, 2111 Garcia, CB 1572 Garcia, D 60, 310, 818 Garcia, MV 175 Garcia, R 2599 García Carazo, S 355 García de la Peña, P 1492 Garcia Monaco, R 175, 188 Garcia Salinas, R 2563 Garcia-Aparicio, AM 1045 García-Arias, M 355 Garcia-Carrasco, Sr., M 1389 Garcia-Dopico, JA 1166, 2115, 2134 Garcia-Fernandez, C 25 García-González, AJ 2349 García-Hernández, FJ 609, 1492 García-Iglesias, T 250 García-Martínez, A 1518, 1523 Garcia-Montojo, M 1084 Garcia-Valladares, I 1313 Garcia-Vicuña, C 1045 Garcia-Vicuña, R 319 Gardam, M 118 Gardiner, EE 2105 Gardner, GC 1046 Gardner-Medwin, J 257 Garen, T 682 Garg, S 84, 1003 Garland, A 2573 Garment, AR 1666 Garneau, K 119 Garrelfs, M 82 Garrido, J 191 Garris, CP 1855 Garrood, T 1274 Garside, P 203 Garvin, K 1179, 2112 Garyfallos, A 901 Garza-Garcia, A 23 Gasca Martínez, V 665 Gaston, JH 517 Gatfossé, M 1955 Gathany, T 144, 1246 Gattorno, M 273, 306, 988, 1686, 1964, 1973, 2452 Gaudin, P 180, 2234 Gaugler, B 1738 Gaujoux-Viala, C 132, 1283 Gauthier, C 646, 937 Gauthier, G 919, 1333
Gay, RE 42, 45, 46, 366, 989, 1671, 1672, 1923, 2519, 2520, 2536, 2605 Gay, S 42, 45, 46, 366, 832, 989, 1007, 1671, 1672, 1823, 1923, 2519, 2520, 2536, 2605 Gaylis, NB 2250 Gebhardt, C 1689 Geborek, P 398, 432, 436, 459, 1692, 2229, 2513, 2515 Gebretsadik, T 587, 588, 2280 Geenen, R 2407 Geetha, D 2432 Gehér, P 517 Geijer, M 504 Geirsson, ÁJ 2136 Gelber, AC 2486 Gelfand, J 508, 782, 2533 Gelhorn, H 1863 Geller, ML 1107 Gemmen, E 126 Gencoglu, H 2094 Gendreau, RM 738, 1908 Genesys Consortium 1496 Genevay, S 1068 Genovese, MC 378, 2236, 2627 Genovese, MC 401, 402, 403, 420, 427, 2191, 2217, 2591, 2594 Gensler, LS 153, 505, 512, 518, 2531 Geny, B 717 George, AJT 1274 Georgel, P 978, 1001 Georgiou, A 699 Gerard, HC 1940, 1948, 2617 Gerards, A 431 Gerdan, V 541, 550, 1974 Geri, G 577, 791, 2394, 2399, 2450, 2620 Gerlag, D 82, 279 Gerlag, DM 58, 313, 371, 770, 1821, 1843, 2154, 2177 Gerlag, DM 969 Gerli, R 1201 German, A 2011 German BIKER Registry collaborative group 260 Germanò, G 189, 1520 Germinario, A 1953 Gerstein, M 2333 Gersuk, VH 2170 Geslani, G 666 Geurts, MA 1695 Ghahary, A 1836 Ghassemi-Nejad, S 734 Ghazarian, SR 1460 Ghazi, E 249, 617 Ghiadoni, L 2263 Ghillani-Dalbin, P 19, 20, 1753 Ghinoi, A 189 Ghio, D 290 Ghodke, Y 1251, 1255 Ghodsi, Z 2386 Ghomrawi, H 1666, 1694 Ghoreishi-Haack, N 1773 Ghosh, P 656 Ghosh*, P 997 Ghrenassia, E 1459 Ghushchyan, V 893 Giacomelli, C 942, 1942 Giacomelli, R 673, 1201 Giampoli, E 1075 Giannini, EH 265, 721, 2445, 2454 Giannoukas, A 1071 Giardina, A 1201 Gibofsky, A 1281 Gibson, DS 307 Gibson, M 750 Gigante, MR 270 Gignac, MA 886, 2292, 2506 Gilchrist, DS 1673 Giles, I 14, 18, 23, 2279, 2288 Giles, JT 1182, 1642 Gilfix, B 1803 Gilio, M 1289 Gilkeson, GS 68, 150, 157, 557, 569, 632, 633, 634, 636, 637, 639, 641, 642, 1663, 2277, 2476, 2477 Gill, G 2050 Gill, R 2555 Gill, RR 2293 Gill, TM 1721 Gilliam, BE 287, 300, 302, 309 Gillis, M 724 Gilsenan, C 1722 Gilson, M 2050 Giltiay, NV 2548 Gimbel, J 741 Gimona, A 1016, 1029 Ginzler, E 584, 591, 592, 2472, 2602 Giorgerini, V 2381, 2382 Giovannini, L 1287 Girard, M 2006 Girgis, R 693 Giron, M 1148 Gisondi, P 2486F Gitelman, D 751, 2456 Giuggioli, D 688, 689, 1454 Giusti, N 1519 Gladman, DD 785, 1395, 2269, 2275 Gladman, D 602 Gladman, DD 4, 522, 524, 525, 537, 544, 549, 580, 591, 592, 599, 661, 781, 1314, 1325, 1327, 1331, 1332, 1334, 1353, 1357, 1360, 1361, 1362, 1363, 1364, 1365, 1368, 1375, 1383, 1385, 1386, 1388, 1398, 1649, 1651, 1708, 2206, 2259, 2262, 2282, 2284, 2285, 2301, 2302, 2486C, 2486E Gladstein, GS 2190 Glant, TT 734, 816, 1008, 1342, 1755, 1760, 1921, 1928, 1929, 2335 Glaser, C 1321 Glass, D 283 Glass, DN 1686, 1688 Glatigny, S 1701 Glazebrook, KN 213, 1617 Glenn, SB 489, 649, 1370 Glickstein, L 975 Glickstein, SL 334 GLORIA study group 2000 GLOW Investigators 829 Glue, C 1622 Gnann, H 534 Gnuegge, L 1736 GO-RAISE Clinical Investigators 423 GO-REVEAL Clinical Investigators 2206 Gobbo, M 1311 Gobeaux, C 685 Godeau, B 438, 858, 1500, 1641 Godinez, F 206 Godinho, F 1317 Goeb, V 488, 1302 Goekoop-Ruiterman, Y 418 Goemaere, S 1104 Goertz, H 892, 894 Goeschl, L 817, 1657, 2359 Goesling, J 1911, 1912, 2421 Goggins, J 1979 Gogia, M 1025, 1037 GOGO Investigators 825 Gohr, C 1800 Goins, RT 1670 Goker, B 1994, 2004 Gokhale, A 40 Goldbach-Mansky, RT 60, 310, 818, 2451 Goldenberg, D 1438 Goldenstein-Schainberg, C 222, 303, 1486 Golder, V 1400 Goldermann, R 1253 Goldring, SR 1065 Goldsmith, DP 2028 Goldsmith, S 1585 Goldstein, I 2333 Golightly, YM 881, 1552, 1556 Goll, GL 2184 Gomar, F 1782 Gómara, MJ 316, 2138 Gomes, A 2346 Gomes, J 2026 Gomez -Caballero, M 1205 Gomez Caballero, ME 450 Gomez Puerta, JA 316, 450, 2138 Gomez Rey, G 890, 891, 1604 Gomez- Puerta, JA 1205 Gomez- Rodriguez-Bethencourt, MA 1166, 2134 Gómez-Bañuelos, E 11 Gomez-Hassan, D 2264 Gomez-Martin, D 854, 1009 Gomez-Reino, JJ 192, 444, 1197, 1238, 1645, 1646, 2209, 2231, 2242 Gomez-Vaquero, C 1524 Gomiero, AB 1562 Goncalves, C 581, 1647 Gonçalves, CR 2397 Gong, Y 774 Gono, T 227, 615, 706, 1483, 1527, 1965, 2319 Gonzalez, A 1439 Gonzalez, EB 613, 666, 726, 1452, 1477, 2429 Gonzalez, JM 453 Gonzalez Expósito, Sr., A 1316 Gonzalez Fernandez, Sr., C 1316 González López, JJ 2253 González López, M 81 González Rodríguez, C 2169 Gonzalez Vela, MDC 81 González-Alvaro, I 57, 319, 343, 1173, 2160 Gonzalez-Diaz, A 1166, 2134 Gonzalez-Dominguez, J 1323 González-Escribano, MF 2160 Gonzalez-Gay, M 790, 1494 González-Gay, MA 1044, 1950, 1968 Gonzalez-Lopez, L 250 González-López, MA 1968 Gonzalez-Malaver, F 321 Gonzalez-Reyes, JA 725 González-Vela, MC 1968 Gooberman-Hill, R 1061 Goode, AP 881 Goodfellow, R 1146 Goodfield, M 2486F Goodman, S 915, 2416 Goodman, SM 1694, 2224 Goodpaster, BH 1560, 2611 Goodson, N 1097, 1105 Gopalakrishnan, R 489 Gordon, C 1847, 2265, 2270, 2271, 2442, 2444 2011 <strong>Program</strong> <strong>Book</strong> 353 abstract author Index
- Page 1 and 2:
program B O O K Pre-Conference Cour
- Page 3 and 4:
program B O O K ABOUT ACR/ARHP EDUC
- Page 5 and 6:
TABLE OF CONTENTS POLICIES Copyrigh
- Page 7 and 8:
TABLE OF CONTENTS ACR Immunology Up
- Page 9 and 10:
TABLE OF CONTENTS Vasculitis Poster
- Page 11 and 12:
However, the ACR continues to requi
- Page 13 and 14:
MEETING NAVIGATION GUIDE To navigat
- Page 15 and 16:
Newsroom Located in room W175c, use
- Page 17:
Guided Poster Tours Guided poster t
- Page 20 and 21:
FRIDAY November 4, 2011 9:15 am Ult
- Page 22 and 23:
SATURDAY, NOVEMBER 5, 2011 12:00 -
- Page 24 and 25:
SATURDAY November 5, 2011 8:35 am T
- Page 26 and 27:
SATURDAY November 5, 2011 Pain: Pat
- Page 28 and 29:
SUNDAY November 6, 2011 SUNDAY, NOV
- Page 30 and 31:
SUNDAY November 6, 2011 Upon comple
- Page 32 and 33:
EXHIBITS 10:00 am - 5:00 pm INNOVAT
- Page 34 and 35:
SUNDAY November 6, 2011 ARHP SPECIA
- Page 36 and 37:
SUNDAY November 6, 2011 W179b Rheum
- Page 38 and 39:
3:15 pm 732. Notch Signaling Pathwa
- Page 40 and 41:
SUNDAY November 6, 2011 3:15 pm 756
- Page 42 and 43:
SUNDAY November 6, 2011 Children’
- Page 44 and 45:
SUNDAY November 6, 2011 3:00 pm 791
- Page 46 and 47:
3:30 pm Demonstration and Practice
- Page 48 and 49:
Yasser M. El Miedany 1 , Maha El Ga
- Page 50 and 51:
SUNDAY November 6, 2011 48 Musculos
- Page 52 and 53:
SUNDAY November 6, 2011 5:15 pm 852
- Page 54 and 55:
SUNDAY November 6, 2011 52 4:55 pm
- Page 56 and 57:
MONDAY, NOVEMBER 7, 2011 ACR/ARHP R
- Page 58 and 59:
MONDAY November 7, 2011 W185a Scler
- Page 60 and 61:
MONDAY November 7, 2011 Upon comple
- Page 62 and 63:
Upon completion of this session, pa
- Page 64 and 65:
MONDAY November 7, 2011 W187b Basic
- Page 66 and 67:
MONDAY November 7, 2011 2:30 pm Cel
- Page 68 and 69:
MONDAY November 7, 2011 Indianapoli
- Page 70 and 71:
3:45 pm 1628. Association of Knee P
- Page 72 and 73:
MONDAY November 7, 2011 Glostrup, C
- Page 74 and 75:
MONDAY November 7, 2011 3:33 pm A R
- Page 76 and 77:
MONDAY November 7, 2011 4:30 pm Ris
- Page 78 and 79:
Institutet, Stockholm, Sweden, 6 Un
- Page 80 and 81:
5:45 pm 1700. Successful Dose De-Es
- Page 82 and 83:
MONDAY November 7, 2011 Michigan, A
- Page 84 and 85:
MONDAY November 7, 2011 4:45 pm 172
- Page 86 and 87:
MONDAY November 7, 2011 5:25 pm Imp
- Page 88 and 89:
TUESDAY November 8, 2011 ARHP CONCU
- Page 90 and 91:
TUESDAY November 8, 2011 9:25 am Is
- Page 92 and 93:
ACR PRACTICE ISSUE 9:30 - 10:30 am
- Page 94 and 95:
TUESDAY November 8, 2011 noon 2431.
- Page 96 and 97:
TUESDAY November 8, 2011 W186b Vasc
- Page 98 and 99:
ACR CLINICAL SYMPOSIA 2:30 - 4:00 p
- Page 100 and 101:
TUESDAY November 8, 2011 3:45 pm 24
- Page 102 and 103:
TUESDAY November 8, 2011 University
- Page 104 and 105:
TUESDAY November 8, 2011 and Oncolo
- Page 106 and 107:
Italy, 3 Hospital Universitario La
- Page 108 and 109:
3:10 pm Case Study Diane V. Lacaill
- Page 110 and 111:
• discuss the evidence to support
- Page 112 and 113:
TUESDAY November 8, 2011 4:45 pm 25
- Page 114 and 115:
5:15 pm 2532. Selection of Patients
- Page 116 and 117:
TUESDAY November 8, 2011 ACR/ARHP C
- Page 118 and 119:
WEDNESDAY, NOVEMBER 9, 2011 ACR/ARH
- Page 120 and 121:
9:00 am Mechanisms of Thrombosis in
- Page 122 and 123:
WEDNESDAY November 9, 2011 A. Kopec
- Page 124 and 125:
WEDNESDAY November 9, 2011 9:15 am
- Page 126 and 127:
WEDNESDAY November 9, 2011 9:45 am
- Page 128 and 129:
WEDNESDAY November 9, 2011 11:45 am
- Page 130 and 131:
WEDNESDAY November 9, 2011 Graduate
- Page 132 and 133:
11:00 am The Process: Defining Appr
- Page 134 and 135:
ACR Poster Session A 11. Myocardial
- Page 136 and 137:
ACR Poster Session A 37. Regulation
- Page 138 and 139:
ACR Poster Session A 64. Interleuki
- Page 140 and 141:
ACR Poster Session A Mexico City, M
- Page 142 and 143:
ACR Poster Session A 121. An Analys
- Page 144 and 145:
ACR Poster Session A 146. National
- Page 146 and 147:
ACR Poster Session A 165. Genome-Wi
- Page 148 and 149:
ACR Poster Session A 185. US Examin
- Page 150 and 151:
ACR Poster Session A Jones 1 , Andr
- Page 152 and 153:
ACR Poster Session A Gerald J. D. H
- Page 154 and 155:
ACR Poster Session A 258. Etanercep
- Page 156 and 157:
ACR Poster Session A GA, 6 Hospital
- Page 158 and 159:
ACR Poster Session A 305. Pathway-B
- Page 160 and 161:
ACR Poster Session A 328. Near Miss
- Page 162 and 163:
ACR Poster Session A 351. A Novel M
- Page 164 and 165:
ACR Poster Session A Sugihara 6 , K
- Page 166 and 167:
ACR Poster Session A 398. Rituximab
- Page 168 and 169:
ACR Poster Session A & Johnson Phar
- Page 170 and 171:
ACR Poster Session A 436. Predicted
- Page 172 and 173:
ACR Poster Session A Tomomi Tsuru 1
- Page 174 and 175:
ACR Poster Session A 479. Follow up
- Page 176 and 177:
ACR Poster Session A 496. A Chimeri
- Page 178 and 179:
ACR Poster Session A 518. Associati
- Page 180 and 181:
ACR Poster Session A Piestany, Slov
- Page 182 and 183:
ACR Poster Session A 576. Fn14 Defi
- Page 184 and 185:
ACR Poster Session A 593. Plasma Le
- Page 186 and 187:
ACR Poster Session A 611. Why Do Lu
- Page 188 and 189:
ACR Poster Session A 634. Associati
- Page 190 and 191:
ACR Poster Session A Alarcon-Riquel
- Page 192 and 193:
ACR Poster Session A Laboratories,
- Page 194 and 195:
ACR Poster Session A Movsisyan, Lid
- Page 196 and 197:
ACR Poster Session A Th1 Cells Expa
- Page 198 and 199:
ACR/ARHP Poster Session B College o
- Page 200 and 201:
ACR/ARHP Poster Session B 920. Econ
- Page 202 and 203:
ACR/ARHP Poster Session B Study. A.
- Page 204 and 205:
ACR/ARHP Poster Session B 974. Dise
- Page 206 and 207:
ACR/ARHP Poster Session B 1001. Mic
- Page 208 and 209:
ACR/ARHP Poster Session B 206 Khann
- Page 210 and 211:
ACR/ARHP Poster Session B 208 Pulmo
- Page 212 and 213:
ACR/ARHP Poster Session B Swearinge
- Page 214 and 215:
ACR/ARHP Poster Session B 212 Felds
- Page 216 and 217:
ACR/ARHP Poster Session B 214 Corbi
- Page 218 and 219:
ACR/ARHP Poster Session B 1161. End
- Page 220 and 221:
ACR/ARHP Poster Session B 1182. Uri
- Page 222 and 223:
ACR/ARHP Poster Session B 1205. A S
- Page 224 and 225:
ACR/ARHP Poster Session B 222 Murth
- Page 226 and 227:
ACR/ARHP Poster Session B San Diego
- Page 228 and 229:
ACR/ARHP Poster Session B 1266. Eva
- Page 230 and 231:
ACR/ARHP Poster Session B 1296. Pat
- Page 232 and 233:
ACR/ARHP Poster Session B 230 1320.
- Page 234 and 235:
ACR/ARHP Poster Session B 1348. Syn
- Page 236 and 237:
ACR/ARHP Poster Session B 1375. Ant
- Page 238 and 239:
ACR/ARHP Poster Session B 1398. Cli
- Page 240 and 241:
ACR/ARHP Poster Session B Baltimore
- Page 242 and 243:
ACR/ARHP Poster Session B 1451. Ele
- Page 244 and 245:
ACR/ARHP Poster Session B Sclerosis
- Page 246 and 247:
ACR/ARHP Poster Session B 1496. Evi
- Page 248 and 249:
ACR/ARHP Poster Session B 1518. Pro
- Page 250 and 251:
ACR/ARHP Poster Session B Hagen 1 ,
- Page 252 and 253:
ACR/ARHP Poster Session B ARHP Clin
- Page 254 and 255:
ACR/ARHP Poster Session C Karl Eger
- Page 256 and 257:
ACR/ARHP Poster Session C Tampere S
- Page 258 and 259:
ACR/ARHP Poster Session C 256 1 Jun
- Page 260 and 261:
ACR/ARHP Poster Session C Universit
- Page 262 and 263:
ACR/ARHP Poster Session C 1864. Epi
- Page 264 and 265:
ACR/ARHP Poster Session C 262 Hospi
- Page 266 and 267:
ACR/ARHP Poster Session C 2 Biogen
- Page 268 and 269:
ACR/ARHP Poster Session C 1945. Cir
- Page 270 and 271:
ACR/ARHP Poster Session C 268 1974.
- Page 272 and 273:
ACR/ARHP Poster Session C 2003. Eff
- Page 274 and 275:
ACR/ARHP Poster Session C Hosp Gast
- Page 276 and 277:
ACR/ARHP Poster Session C Toronto,
- Page 278 and 279:
ACR/ARHP Poster Session C Francisco
- Page 280 and 281:
ACR/ARHP Poster Session C 2105. Inc
- Page 282 and 283:
ACR/ARHP Poster Session C Universit
- Page 284 and 285:
ACR/ARHP Poster Session C 282 2151.
- Page 286 and 287:
ACR/ARHP Poster Session C 284 2175.
- Page 288 and 289:
ACR/ARHP Poster Session C 286 2196.
- Page 290 and 291:
ACR/ARHP Poster Session C 2217. Lon
- Page 292 and 293:
ACR/ARHP Poster Session C Research
- Page 294 and 295:
ACR/ARHP Poster Session C 2258. sIL
- Page 296 and 297:
ACR/ARHP Poster Session C 2290. The
- Page 298 and 299:
ACR/ARHP Poster Session C Universit
- Page 300 and 301:
ACR/ARHP Poster Session C 2345. IL-
- Page 302 and 303:
ACR/ARHP Poster Session C 2376. Gra
- Page 304 and 305: ACR/ARHP Poster Session C 2399. Spe
- Page 306 and 307: REF Industry Roundtable-supported S
- Page 308 and 309: REF Industry Roundtable-supported S
- Page 310 and 311: Industry-supported POST-CONFERENCE
- Page 312 and 313: CERTIFICATES OF CME CREDIT OR PARTI
- Page 314 and 315: 2011 ACR/ARHP Annual Meeting Leader
- Page 316 and 317: 2011 ACR/ARHP Annual Meeting Leader
- Page 318 and 319: EXHIBITORS Abbott Pharmaceuticals B
- Page 320 and 321: EXHIBITORS Lippincott, Williams and
- Page 322 and 323: acknowledgements The ACR, the ARHP
- Page 324 and 325: Invited Speaker /Moderator Index 32
- Page 326 and 327: Invited Speaker /Moderator Index 32
- Page 328 and 329: Invited Speaker /Moderator Index Ev
- Page 330 and 331: Invited Speaker /Moderator Index 32
- Page 332 and 333: Invited Speaker /Moderator Index 33
- Page 334 and 335: Invited Speaker /Moderator Index Mu
- Page 336 and 337: Invited Speaker /Moderator Index Om
- Page 338 and 339: Invited Speaker /Moderator Index St
- Page 340 and 341: Invited Speaker /Moderator Index Wi
- Page 342 and 343: aBSTRACT author Index 340 Alpers, C
- Page 344 and 345: aBSTRACT author Index Bawa, WA 259
- Page 346 and 347: aBSTRACT author Index 344 Broder, A
- Page 348 and 349: aBSTRACT author Index 346 Chaves, L
- Page 350 and 351: aBSTRACT author Index 348 Dalbeth,
- Page 352 and 353: aBSTRACT author Index Eastman, PS 3
- Page 356 and 357: aBSTRACT author Index Gordon, C 4,
- Page 358 and 359: aBSTRACT author Index Hemmati, I 13
- Page 360 and 361: aBSTRACT author Index 358 Ishigatsu
- Page 362 and 363: aBSTRACT author Index 360 Keeling,
- Page 364 and 365: aBSTRACT author Index 362 Kumar, V
- Page 366 and 367: aBSTRACT author Index 364 Lim, M 13
- Page 368 and 369: aBSTRACT author Index 366 Marshall,
- Page 370 and 371: aBSTRACT author Index 368 MMF/AZA L
- Page 372 and 373: aBSTRACT author Index 370 Noel, D 1
- Page 374 and 375: aBSTRACT author Index 372 Pawlita,
- Page 376 and 377: aBSTRACT author Index 374 Ramos, I
- Page 378 and 379: aBSTRACT author Index 376 Rönnblom
- Page 380 and 381: aBSTRACT author Index 378 Shaykevic
- Page 382 and 383: aBSTRACT author Index Su, J 22, 139
- Page 384 and 385: aBSTRACT author Index 382 Tomcik, M
- Page 386 and 387: aBSTRACT author Index 384 Villeneuv
- Page 388 and 389: aBSTRACT author Index 386 Wu, X 650
- Page 390 and 391: abstract keyword Index 388 18FDG PE
- Page 392 and 393: abstract keyword Index 2092, 2113,
- Page 394 and 395: abstract keyword Index 392 macropha
- Page 396 and 397: abstract keyword Index 387, 388, 38
- Page 398 and 399: Abstract Moderator disclosure A Ano
- Page 400 and 401: Abstract Moderator disclosure Jonas
- Page 402 and 403: V van der Heijde, Desiree, MD, PhD
- Page 404 and 405:
Notes 402 2011 Program Book
- Page 406 and 407:
immunosuppressive agents is not rec
- Page 408:
In appropriate patients with psoria